Discover valuable insights for transforming your biopharmaceutical production with our comprehensive resource. We take a deep dive into the latest industry trend of outsourcing buffer and process ...
The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and ...
Nucleus Biologics, a leading provider of custom cell culture solutions and manufacturing technologies for advanced therapies, today announced the launch of NB-Lux™ AI, a next-generation digital ...
Produces 35–500 liters of sterile media and buffers on demand at point-of-use, reducing cost, complexity, and lead times Pod-based, closed single-use system with integrated analytics, QR-code-driven ...
PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Aceto, a leading global provider of specialty materials for life sciences and advanced technology end markets, announced today its acquisition of A&C Bio Buffer ...
Nucleus Biologics launched the Krakatoa ® K500, which the company says is the first bioreactor-scale, pod-based media and buffer manufacturing system designed to deliver sterile solutions on demand ...
We listened to our customers’ frustrations with the complex process of centralized GMP liquid media manufacturing. With the Krakatoa® K500, we begin a journey to co-locate both media and buffer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results